Viridian Therapeutics, Inc.
VRDN · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$35 | -$101 | -$87 | -$80 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $11 | $11 | $10 | $9 |
| Change in WC | -$60 | $16 | -$14 | $0 |
| Other Non-Cash | -$1 | -$1 | -$2 | -$3 |
| Operating Cash Flow | -$85 | -$75 | -$93 | -$73 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$0 | -$0 | -$0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$14 | -$56 | -$71 | -$182 |
| Inv. Sales/Matur. | $140 | $132 | $171 | $119 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $126 | $76 | $100 | -$63 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $10 | $0 | $5 | $34 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $1 | $1 | $4 | $2 |
| Financing Cash Flow | $11 | $1 | $9 | $36 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $52 | $1 | $17 | -$101 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $117 | $116 | $100 | $200 |
| End Cash | $170 | $117 | $116 | $100 |
| Free Cash Flow | -$85 | -$75 | -$93 | -$73 |